NCT04444024

Brief Summary

A multicenter, retrospective clinical study was carried out in the medical records management system of 6 hospitals in Tianjin. Patients who were suffered with Coronary heart disease angina pectoris and underwent coronary angiography are collected. The investigators collect and analyze the demographics, laboratory information, clinical outcome data, and coronary angiographic data of patients. To explore the correlation between hypercholesterolemia and the degree of coronary artery stenosis of Coronary heart disease angina pectoris, and to further research the influence of hypertension on total cholesterol level and coronary artery stenosis, and provide guidance for clinical prevention and treatment.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 17, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 23, 2020

Completed
2 months until next milestone

Study Start

First participant enrolled

September 1, 2020

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2021

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2021

Completed
Last Updated

June 23, 2020

Status Verified

June 1, 2020

Enrollment Period

6 months

First QC Date

June 17, 2020

Last Update Submit

June 21, 2020

Conditions

Outcome Measures

Primary Outcomes (16)

  • Fasting blood glucose in clinical biochemical tests.

    In the hospital medical record management system, the investigators collect the fasting blood glucose data of the first day of hospitalization of the patients.

    one year

  • Glycated hemoglobin in clinical biochemical tests.

    In the hospital medical record management system, the investigators collect the glycated hemoglobin data of the first day of hospitalization of the patients.

    one year

  • Total cholesterol in clinical biochemical tests.

    In the hospital medical record management system, the investigators collect the total cholesterol data of the first day of hospitalization of the patients.

    one year

  • Triglyceride in clinical biochemical tests.

    In the hospital medical record management system, the investigators collect the triglyceride data of the first day of hospitalization of the patients.

    one year

  • Low density lipoprotein cholesterol in clinical biochemical tests.

    In the hospital medical record management system, the investigators collect the low density lipoprotein cholesterol data of the first day of hospitalization of the patients.

    one year

  • High density lipoprotein cholesterol in clinical biochemical tests.

    In the hospital medical record management system, the investigators collect the high density lipoprotein cholesterol data of the first day of hospitalization of the patients.

    one year

  • C-reactive protein in clinical biochemical tests.

    In the hospital medical record management system, the investigators collect the C-reactive protein data of the first day of hospitalization of the patients.

    one year

  • Fibrinogen in clinical biochemical tests.

    In the hospital medical record management system, the investigators collect the fibrinogen data of the first day of hospitalization of the patients.

    one year

  • Coronary angiography data in imaging examination.

    In the hospital medical record management system, the investigators collect coronary angiography data of the patient's hospitalization.

    one year

  • Age in demographics.

    In the hospital medical record management system, the investigators collect the age data of the first day of hospitalization of the patients.

    one year

  • Gender in demographics.

    In the hospital medical record management system, the investigators collect the gender data of the first day of hospitalization of the patients.

    one year

  • Ethnicity in demographics.

    In the hospital medical record management system, the investigators collect the ethnicity data of the first day of hospitalization of the patients.

    one year

  • Weight in demographics.

    In the hospital medical record management system, the investigators collect the weight data of the first day of hospitalization of the patients.

    one year

  • Smoking in demographics.

    In the hospital medical record management system, the investigators collect the smoking data of the first day of hospitalization of the patients.

    one year

  • Medical history in demographics.

    In the hospital medical record management system, the investigators collect the medical history data of the first day of hospitalization of the patients.

    one year

  • Blood pressure in demographics.

    In the hospital medical record management system, the investigators collect the blood pressure data of the first day of hospitalization of the patients.

    one year

Secondary Outcomes (2)

  • Evaluate the correlation between total cholesterol level and the degree of coronary artery stenosis

    one year

  • Assess the effect of with or without hypertension on the correlation between total cholesterol level and the degree of coronary artery stenosis

    one year

Study Arms (6)

NTC/-HTN group

Patients with TC \< 5.18 mmol/l, systolic blood pressure \<130 mmHg and diastolic blood pressure \<80 mmHg belong to normal TC/ none hypertension(NTC/-HTN) group.

NTC/+HTN group

Patients with TC \< 5.18 mmol/l, systolic blood pressure ≥130 mmHg or diastolic blood pressure ≥80 mmHg belong to normal TC/ hypertension(NTC/+HTN) group.

BHTC/-HTN group

Patients whose TC is 5.18 ≤ TC \< 6.19 mmol/l, systolic blood pressure \<130 mmHg and diastolic blood pressure \<80 mmHg belong to borderline-high TC/ none hypertension (BHTC/-HTN) group.

BHTC/+HTN group

Patients whose TC is 5.18 ≤ TC \< 6.19 mmol/l, systolic blood pressure ≥130 mmHg or diastolic blood pressure ≥80 mmHg belong to borderline-high TC/ hypertension (BHTC/+HTN) group.

HTC/-HTN group

Patients with TC ≥6.19 mmol/l, systolic blood pressure \<130 mmHg and diastolic blood pressure \<80 mmHg belong to high TC/ none hypertension(HTC/-HTN) group.

HTC/+HTN group

Patients with TC ≥6.19 mmol/l, systolic blood pressure ≥130 mmHg or diastolic blood pressure ≥ 80 mmHg belong to high TC/ hypertension(HTC/+HTN) group.

Eligibility Criteria

Age35 Years - 75 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The collaborative network of Coronary heart disease research medical units formed by the research team includes the First affiliated Hospital of Tianjin University of traditional Chinese Medicine, the Second affiliated Hospital of Tianjin University of traditional Chinese Medicine, Tianjin Nankai Hospital, the affiliated Hospital of Tianjin Institute of traditional Chinese Medicine, Tianjin chest Hospital and Tianjin Medical University General Hospital.

You may qualify if:

  • Patients aged from 35 to 75 years old, male or female.
  • Those who were hospitalized between September 1, 2014 and September 1, 2019.
  • Patients with Coronary heart disease angina pectoris and have undergone coronary angiography in the inpatient department of cardiovascular internal medicine.
  • The diagnosis of hypercholesterolemia, Coronary heart disease angina pectoris and hypertension is accorded with the diagnostic criteria.

You may not qualify if:

  • Those with other cardiac diseases, gastroesophageal reflux disease or hiatal hernia, neurosis, spinal or vertebral artery cervical spondylosis, hyperthyroidism, climacteric syndrome, etc.
  • Those with myocarditis, cardiomyopathy, acute myocardial infarction, third degree of heart failure, severe heart valve disease, major diseases such as malignant tumor and serious metabolic diseases, liver failure or renal failure.
  • Those with psychotic disorders, or cognitive dysfunction.
  • Those of childbearing age and have fertility requirements, or pregnant women or lactating women.
  • Those allergic to iodine contrast medium.
  • Those who are not suitable for the study, as judged by the researcher.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tianjin University of Traditional Chinese Medicine

Tianjin, Tianjin Municipality, 300193, China

Location

Central Study Contacts

Chunquan Yu, Dr.

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
researcher

Study Record Dates

First Submitted

June 17, 2020

First Posted

June 23, 2020

Study Start

September 1, 2020

Primary Completion

March 1, 2021

Study Completion

September 1, 2021

Last Updated

June 23, 2020

Record last verified: 2020-06

Data Sharing

IPD Sharing
Will share

Locations